Business Context and Reporting Period
This Form 8-K Current Report was filed by GRI Bio, Inc. on July 19, 2024. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in La Jolla, California. The report addresses a corporate action regarding its equity financing program.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The only financial figures disclosed relate to the Company's At-The-Market (ATM) offering program:
- Shares Sold to Date: Approximately $961,272 in aggregate gross sales price.
- Additional Shares Authorized: Up to $1,038,886 in aggregate gross sales price.
- Total Program Capacity: Approximately $2,000,158 (sum of sold and newly authorized amounts).
Material Changes
The material change reported is the amendment of the Sales Agreement with H.C. Wainwright & Co., LLC, dated May 20, 2024. The Company filed a prospectus supplement to increase the maximum number of common shares issuable under the agreement by up to $1,038,886. This action expands the Company's ability to raise capital through the existing ATM facility.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard legal opinion regarding the issuance of shares. The primary purpose of the filing is to disclose the expansion of the equity offering program.
Investor Verification Checklist
- Verify the current share price to estimate the number of shares represented by the $1,038,886 increase in the ATM program.
- Review the full Sales Agreement and prospectus supplement (Exhibit 5.1) for specific terms, commissions, and restrictions on share sales.
- Check recent 10-Q or 10-K filings for the Company's current cash position and burn rate to assess the necessity of this additional capital raise.
- Confirm the total number of shares outstanding to calculate potential dilution from the full utilization of the expanded ATM program.